The International Consensus Statement on Allergy and Rhinology: Rhinosinusitis 2021 provides evidence-based recommendations for medical and surgical treatment of the most common forms of rhinosinusitis, along with a comprehensive management algorithm.
- The International Consensus Statement on Allergy and Rhinology: Rhinosinusitis (ICAR-RS) has made foundational progress in understanding and treating rhinologic disease. - ICAR-RS-2021 covers over 180 topics in the forms of evidence-based reviews with recommendations (EBRRs), evidence-based reviews, and literature reviews. - ICAR-RS-2021 executive summary provides a compilation of the evidence-based recommendations for medical and surgical treatment of the most common forms of RS. - A comprehensive evidence-based management algorithm is provided.
“There are many treatments for chronic rhinosinusitis but the most proven ones are salt-water rinses and steroid sprays or washes.”
This is from International Forum of Allergy & Rhinology in 2021 at https://pubmed.ncbi.nlm.nih.gov/33236525/.
Top Five Keywords: acute rhinosinusitis, chronic rhinosinusitis, endoscopic sinus surgery, evidence-based medicine, recurrent acute rhinosinusitis.
Abstract
I.
Executive summary: BACKGROUND: The 5 years since the publication of the first International Consensus Statement on Allergy and Rhinology: Rhinosinusitis (ICAR-RS) has witnessed foundational progress in our understanding and treatment of rhinologic disease. These advances are reflected within the more than 40 new topics covered within the ICAR-RS-2021 as well as updates to the original 140 topics. This executive summary consolidates the evidence-based findings of the document.
Methods: ICAR-RS presents over 180 topics in the forms of evidence-based reviews with recommendations (EBRRs), evidence-based reviews, and literature reviews. The highest grade structured recommendations of the EBRR sections are summarized in this executive summary.
Results: ICAR-RS-2021 covers 22 topics regarding the medical management of RS, which are grade A/B and are presented in the executive summary. Additionally, 4 topics regarding the surgical management of RS are grade A/B and are presented in the executive summary. Finally, a comprehensive evidence-based management algorithm is provided.
Conclusion: This ICAR-RS-2021 executive summary provides a compilation of the evidence-based recommendations for medical and surgical treatment of the most common forms of RS.
Keywords: acute rhinosinusitis; chronic rhinosinusitis; endoscopic sinus surgery; evidence-based medicine; recurrent acute rhinosinusitis; rhinosinusitis; systematic review.
© 2021 ARS-AAOA, LLC.